• Nadia Care

  Participated · Equity · Mar 2026

  Nadia Care operates a hybrid model combining community-centered, in-home care and virtual support delivered by Maternity Navigators and multidisciplinary care teams. Its services include care coordination, benefit sign-up and navigation, lactation support, nutrition services, and prenatal and new parent education. The company is led by CEO Adaeze Enekwechi and is based in Washington, DC. Nadia Care has served about 4,000 members and reports measurable improvements in outcomes—reductions in NICU days, low birth weight, preterm births, and emergency room visits. The recently raised $12M will be used to expand operations and advance its development efforts. The article does not disclose revenue, valuation, or prior financing details.

• Millie

  Participated · Series A · Feb 2025

  Millie operates a hybrid maternity clinic model that combines in-person care at its clinics with virtual visits, remote monitoring, and a proprietary app. The company offers maternity and gynecology care as well as postpartum coaching, mental health support, and nutrition counseling. Millie works with all major insurance companies and provides both in-person and virtual support through a tech platform with patient monitoring tools. Founder Anu Sharma launched Millie in 2022 after experiencing pregnancy complications and identifying gaps in care. The company describes its model as capital efficient and increasingly powered by AI-enabled workflows in collaboration with payors and health system partners. Millie competes with other maternal-care providers such as Quilted Health and Oula and plans to expand its physical footprint and technology services across California. Millie is a Berkeley, CA-based maternity clinic and app-enabled care provider that guides patients from 48 hours after a positive pregnancy test through one year postpartum. The service pairs each patient with a care team including an OB-GYN, a midwife, and a doula, delivering coordinated clinical and nonclinical support. Millie's offerings combine proactive medical insight, virtual and in-clinic monitoring, and at-home monitoring tools such as blood pressure cuffs. Its digital app provides around-the-clock messaging with providers, a social network, mental health support, nutrition counseling, lactation support, and digital health checks. The company conducts three visits with patients, the first occurring at the patient's home within one week postpartum, and emphasizes accessible, patient-centered care. Millie recently closed a $4M seed round and plans to open a physical clinic next to the Alta Bates Campus in Berkeley on September 26.

• Twentyeight Health

  Participated · Series A · Jan 2025

  Twentyeight Health is a NYC-based digital-first women’s healthcare platform that makes reproductive and sexual healthcare affordable through telemedicine consultations, fast at-home deliveries, and ongoing access to providers for services such as birth control and herpes treatments. The company accepts almost every commercial insurance and Medicaid plan, positioning itself as a broadly accessible alternative to traditional care. It currently serves more than 100,000 users across 43 states. Twentyeight Health raised $10M in a Series A, bringing its total capital raised to $25M. The company intends to use the funds to expand operations and accelerate product development. Bruno Van Tuykom serves as CEO. Twentyeight Health operates a women’s virtual healthcare platform focused on sexual and reproductive care, accepting Medicaid and partnering with culturally competent clinicians. The platform is bilingual (English and Spanish) and aims to serve medically underserved, low-income, and non-urban populations. Since founding in 2018, the company has expanded from six to 34 states and now covers more than 85% of women of reproductive age in the U.S. It has helped over 60,000 individuals access care, with 55% of users on Medicaid, 58% identifying as BIPOC, and 60% living in non-urban areas; 63% of its birth-control users previously lacked access to prescriptions. The company offers free birth control to uninsured users through a partnership with the Contraceptive Access Fund of Bedsider and donates 2% of revenues to related organizations. With recent funding, Twentyeight Health plans to expand nonprofit partnerships, grow its services and footprint, and improve the quality of its telehealth offerings. Twentyeight Health offers telemedicine reproductive-health services focused on contraception, providing online medical questionnaires reviewed by U.S. board-certified doctors and access to more than 100 FDA-approved birth control options. Customers receive shipments within three days and ongoing care via audio consultations and doctor follow-up messages. The company emphasizes serving Medicaid, underinsured, and uninsured women and works with partners such as Bottomless Closet and eight CUNY colleges to reach underserved populations. Twentyeight Health is the only telemedicine contraception provider noted in the article that accepts Medicaid and also partners with Bedsider’s Contraceptive Access Fund to provide free birth control to uninsured patients. The company donates 2% of its revenue to Bedsider and the National Institute for Reproductive Health. Launched in 2018, Twentyeight Health currently operates across Florida, Maryland, New York, New Jersey, North Carolina, and Pennsylvania and plans to use new funding to expand services across the U.S.

• Seven Starling

  Led · Series A · Aug 2024

  Founded in 2020 by Harvard Business School classmates Tina Keshani, Julia Cole, and Sophia Richter, Seven Starling delivers technology-enabled maternal mental-health care. Its platform combines clinical evaluations, medication management, and both individual and group therapy to treat depression, anxiety, and related conditions tied to parenthood. All services are covered by insurance, helping patients access support without prohibitive out-of-pocket costs. The company plans to use new capital to expand into a dozen additional states by the end of 2026. Seven Starling’s care model targets postpartum, infertility, miscarriage, and loss, aiming to close gaps in traditional maternal health services. To date, the startup has raised $21.8 million across three rounds, giving it resources to scale its virtual operations and provider network.

• Novocuff

  Participated · Series A · Jul 2024

  Novocuff develops the Novocuff Cervical Control System (CCS), a medical device designed to stabilize and close the cervix to retain amniotic fluid and sustain cervical length with the goal of extending pregnancy. The company is focused on improving pregnancy outcomes and reducing preterm births caused by PPROM and cervical shortening. Novocuff says it aims to transform the standard of care and bring the device to global markets, including low- and middle-income countries. Proceeds from an oversubscribed $26 million Series A will fund team expansion, a U.S. multi-center pivotal clinical trial planned for early 2025, pursuit of marketing authorization, and early-stage commercialization. The company completed an initial $2 million seed round prior to the Series A and has added clinical hires Kathryn Wine (VP, Clinical Affairs) and Marissa VanDeVeer (Clinical Engineer). Novocuff frames its work against the global burden of preterm birth, citing WHO data that preterm complications caused roughly 1 million infant deaths in 2020.

No current team members are available.